[Specific active immunotherapy of cancer].
D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage; D000941:Antigens / Q000008:administration & dosage; D000951:Antigens, Neoplasm / Q000302:isolation & purification; D004247:DNA / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use; D017710:Lymphocyte Transfusion; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012313:RNA / Q000627:therapeutic use; D011817:Rabbits; D014165:Transfer Factor / Q000627:therapeutic use
D000912:Antibodies, Neoplasm; D000941:Antigens; D000951:Antigens, Neoplasm; D014165:Transfer Factor; D012313:RNA; D004247:DNA; D007372:Interferons
Inmunoterapia activa específica del cáncer.